Thanks - to be determined on DiCE's lead program; but the idea is to replace an antibody with a small molecule to gain delivery advantages.
158 karma · joined June 12, 2015
Daphne Koller is incredible - will add her work next time. Papers are often a starting point/PoC for a lot of companies in life sciences. IP and other components come out as a result.
Appreciate it.